1,152 material Form 8-K filings that 918 companies we cover made with the SEC in October 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Archrock reported third-quarter 2025 revenue of $382.4 million, up from $292.2 million a year earlier, and net income of $71.2 million, or $0.40 per share, compared with $37.5 million, or $0.22, in the third quarter of 2024. The company raised its full-year 2025 Adjusted EBITDA guidance to $835 million to $850 million and increased its share repurchase authorization by $100 million.
Q3 2025 revenue was $382.4 million, compared with $292.2 million in Q3 2024.
Net income was $71.2 million, or $0.40 per share, versus $37.5 million, or $0.22, a year earlier.
Full-year 2025 Adjusted EBITDA guidance raised to $835 million to $850 million.
Share repurchase authorization increased by $100 million, with $130.4 million available as of October 22, 2025.
Centene reported third quarter 2025 results with a GAAP diluted loss of $(13.50) per share, driven by a $6.7 billion non-cash goodwill impairment, while adjusted diluted EPS was $0.50. The company raised its full year 2025 adjusted diluted EPS forecast by $0.25 to at least $2.00, but its updated GAAP forecast is a diluted loss per share not to exceed $(12.85).
Total revenues were $49.7 billion and premium and service revenues rose 22% to $44.9 billion from $36.9 billion a year earlier.
Health benefits ratio rose to 92.7% from 89.2% in the third quarter of 2024.
Adjusted diluted EPS forecast for 2025 increased to at least $2.00 from $1.75.
Debt-to-capital ratio was 45.5% at September 30, 2025, after the reduction to retained earnings from the impairment.
Teradyne said Michelle Turner will succeed Sanjay Mehta as Vice President, Chief Financial Officer, and Treasurer effective November 3, 2025, and will also serve as principal financial and accounting officer. Mehta remains with the company as an executive advisor and plans to retire in 2026. The filing describes a leadership change with no financial results included.
Turner's offer letter sets a base salary of $640,000 and a target annual cash bonus of 100% of base salary.
Company will grant Turner an equity award with a target value of $6,800,000 on November 3, 2025, plus a $200,000 sign-on bonus and a $150,000 relocation payment.
Turner's change of control agreement provides two years of severance payments at the annual Model Compensation rate.
Mehta, CFO since 2019, will stay on as an executive advisor and plans to retire in 2026.
Kadant reported third quarter 2025 revenue of $271.6 million, flat with the prior year, while net income fell 12% to $27.7 million and diluted GAAP EPS fell to $2.35 from $2.68. The company raised its 2025 revenue guidance to $1.036 billion to $1.046 billion but cut its 2025 GAAP EPS guidance to $8.52 to $8.72, and kept adjusted EPS guidance at $9.05 to $9.25.
Q3 2025 revenue was $271.6 million, flat versus $271.6 million in Q3 2024; organic revenue fell 4%.
Q3 adjusted EBITDA fell 8% to $58.0 million, and adjusted EBITDA margin was 21.4% versus 23.3%.
2025 revenue guidance raised to $1.036 billion to $1.046 billion from $1.020 billion to $1.040 billion.
2025 GAAP EPS guidance cut to $8.52 to $8.72 from $8.89 to $9.09; adjusted EPS guidance maintained at $9.05 to $9.25.
Kulicke and Soffa CEO Fusen Chen will retire as President, CEO and board member effective December 1, 2025, due to health reasons, and will advise the board for 12 months afterward. CFO Lester Wong was appointed interim CEO effective immediately while the board searches for a permanent successor, and the company reaffirmed its fourth quarter fiscal 2025 outlook.
Fusen Chen retires as President and CEO effective December 1, 2025, and will receive $75,000 per month as an advisor for 12 months
Lester Wong, Executive Vice President and CFO, named interim CEO effective October 28, 2025, with a monthly stipend of S$35,000 and RSUs valued at S$600,000
Company reaffirmed fourth quarter fiscal 2025 outlook and plans to report results on November 19, 2025
World Kinect said its board named Ira M. Birns, the current President and Chief Financial Officer, as chief executive effective January 1, 2026, and Michael J. Kasbar will step down as CEO on December 31, 2025 to become Executive Chairman. The company also named Jose-Miguel (Mike) Tejada as chief financial officer effective October 24, 2025, appointed Andrea B. Smith to the board, and amended its bylaws to add two authorized director seats. The filing describes a leadership transition and does not report financial results.
Ira M. Birns becomes CEO and a board member effective January 1, 2026, with salary set at $900,000 per year.
Michael J. Kasbar steps down as CEO on December 31, 2025 and becomes Executive Chairman, with salary of $850,000 per year.
Jose-Miguel (Mike) Tejada named Executive Vice President and CFO effective October 24, 2025; Andrea B. Smith joined the board effective October 24, 2025.
Board amended the bylaws to increase authorized directors by two; John Rau becomes President effective January 1, 2026.
Regency Centers reported third quarter 2025 Nareit FFO of $1.15 per diluted share, up from $1.07 a year earlier, and raised its full-year 2025 Nareit FFO guidance to $4.62 to $4.64 per diluted share from $4.59 to $4.63. The board also declared a common dividend of $0.755 per share, an increase of approximately 7.1%, payable January 6, 2026, which matters to shareholders because it raises cash payouts and signals higher expected earnings.
Q3 2025 net income attributable to common shareholders was $0.58 per diluted share, compared with $0.54 in Q3 2024
Q3 2025 Same Property NOI, excluding termination fees, rose 4.8% year over year
2025 Nareit FFO guidance raised to $4.62 to $4.64 per diluted share; Same Property NOI growth guidance raised to +5.25% to +5.5%
Common dividend of $0.755 per share payable January 6, 2026, to holders of record as of December 15, 2025
Ultra Clean Holdings reported third-quarter 2025 revenue of $510.0 million, down from $540.4 million a year earlier and $518.8 million in the prior quarter. The GAAP net loss attributable to the company was $10.9 million, or $0.24 per diluted share, much smaller than the $162.0 million loss in the prior quarter, which included a goodwill impairment. The board also approved a share repurchase program of up to $150 million over three years.
Q3 2025 revenue was $510.0 million, versus $540.4 million in the same quarter of 2024 and $518.8 million in the quarter ended June 27, 2025.
GAAP net loss attributable to the company was $(10.9) million, or $(0.24) per diluted share; non-GAAP net income was $12.9 million, or $0.28 per diluted share.
The company expects fourth-quarter 2025 revenue of $480 million to $530 million and GAAP diluted EPS of $(0.11) to $0.09.
On October 23, 2025, the board approved buybacks of up to $150 million of common stock over a three-year period.
United Parks & Resorts said CFO and Treasurer James Mikolaichik will resign effective November 15, 2025, to pursue another opportunity, and that the departure is not due to any disagreement on financial statements, internal controls, operations, policies or practices. Senior Vice President, Finance James Forrester Jr. will serve as Interim CFO and Treasurer until a permanent successor is named, and the company has not yet set his compensation.
Mikolaichik informed the company of his resignation on October 22, 2025; it takes effect November 15, 2025
James (Jim) W. Forrester Jr., 57, named Interim CFO and Treasurer effective November 15, 2025
Forrester has been Senior Vice President, Finance since November 2024 and was Interim CFO from January 2023 to November 2024
Compensation changes for Forrester have not been determined; the company will file an amendment within four business days once they are
Equity Residential reported third-quarter 2025 diluted EPS of $0.76, up from $0.38 a year earlier, and same store revenues rose 3.0%. The company lowered its full-year 2025 EPS guidance to $2.52 to $2.56 from $2.96 to $3.02, and cut the midpoint of same store revenue guidance, citing weaker demand late in the quarter, especially in Washington, D.C.
Q3 2025 diluted EPS was $0.76 versus $0.38 in Q3 2024; Q3 Normalized FFO per share was $1.02 versus $0.98.
Full-year 2025 EPS guidance was revised to $2.52 to $2.56 from $2.96 to $3.02; same store revenue guidance was revised to 2.5% to 3.0% from 2.6% to 3.2%.
Normalized FFO per share guidance for full-year 2025 was unchanged at $3.98 to $4.02.
Meritage Homes reported third quarter 2025 net earnings of $99 million, down 49% from $196 million a year earlier, as home closing revenue fell 12% to $1.4 billion and home closing gross margin dropped to 19.1% from 24.8%. The company cited increased use of buyer incentives, inventory impairments, terminated land deal charges, and higher SG&A and tax rates. It also guided fourth quarter 2025 diluted EPS to $1.51 to $1.70.
Third quarter diluted EPS was $1.39 versus $2.67 a year earlier; excluding $14.5 million of impairments and terminated land deal charges, adjusted diluted EPS was $1.55.
Home closing revenue was $1.4 billion, down 12%, on 3,685 homes closed, down 7%; average sales price on closings fell 5% to $380,000.
Fourth quarter 2025 guidance calls for home closing revenue of $1.46 to $1.54 billion and diluted EPS of $1.51 to $1.70.
Veralto reported third-quarter 2025 sales of $1,404 million, up 6.9% from a year earlier, and GAAP diluted earnings of $0.95 per share, up from $0.88. The company raised its full-year 2025 adjusted EPS guidance to $3.82 to $3.85 from $3.72 to $3.80, which is a positive signal for shareholders.
Q3 2025 sales rose 6.9% year over year to $1,404 million, with non-GAAP core sales growth of 5.1%
Q3 GAAP diluted EPS was $0.95 versus $0.88 a year earlier; adjusted diluted EPS was $0.99 versus $0.89
Full-year 2025 adjusted EPS guidance raised to $3.82-$3.85 from $3.72-$3.80; Q4 adjusted EPS expected at $0.95-$0.98
Vistra said its subsidiary completed the acquisition of seven natural gas generation facilities on October 22, 2025, under a purchase agreement dated May 15, 2025. The company's press release describes the assets as about 2,600 megawatts of capacity bought from Lotus Infrastructure Partners, with a base price of $1.9 billion before customary adjustments. The filing does not report earnings or guidance effects, so the deal's effect on shareholders depends on how the added capacity performs.
Closing completed October 22, 2025, after receiving all required regulatory approvals.
Base purchase price of $1.9 billion, subject to customary adjustments; funded with cash and assumption of a senior secured credit facility with an existing term loan of about $800 million principal outstanding.
Seven natural gas plants totaling about 2,600 MW in PJM, New England, New York and California.
Element Solutions reported third-quarter 2025 net sales of $656 million, up 2% on a reported basis, and a record $147 million in adjusted EBITDA, up 3%. GAAP net income slipped 3% to $39 million, and the company narrowed its full-year 2025 adjusted EBITDA guidance to the high end of its prior range, which signals management expects its results to hold up through year-end. The company also announced the Micromax acquisition, which it said will not contribute in 2025 but should add meaningfully to earnings growth in 2026.
Q3 2025 net sales were $656 million, up 2% reported and 5% organic, compared with the third quarter of 2024.
Adjusted EBITDA was a record $147 million, up 3% reported, and up 10% excluding the divested MacDermid Graphics Solutions business.
GAAP net income was $39 million, or $0.16 per diluted share, versus $40 million and $0.17 a year earlier; adjusted EPS rose to $0.41 from $0.39.
Full-year 2025 adjusted EBITDA guidance was narrowed to $545 million to $550 million, the highest end of the prior range.
Landstar System reported third-quarter 2025 revenue of $1,205 million, down from $1,214 million a year earlier, and GAAP earnings per share of $0.56, down from $1.41. The results include $0.66 per share of non-cash impairment charges; excluding them, adjusted EPS was $1.22, still below the prior-year $1.41.
Q3 2025 revenue was $1,205 million versus $1,214 million in Q3 2024; operating income was $26.3 million versus $63.1 million.
Three non-cash impairment charges cut EPS by $0.66, including $16.1 million tied to the planned sale of its Mexican subsidiary Landstar Metro.
Adjusted EPS was $1.22 versus $1.41 a year earlier, a decline of 13.5%.
The Board declared a quarterly dividend of $0.40 per share, payable December 9, 2025, to holders of record on November 18, 2025.
Littelfuse agreed on October 24, 2025 to acquire all membership interests of Basler Electric Company from Basler Holdings, LLC for approximately $350 million in cash, subject to post-closing adjustments. The company expects the deal to be accretive to adjusted diluted EPS in 2026 and to close by the end of the fourth quarter of 2025, subject to regulatory approvals, which means shareholders will see the cash outlay and integration effects over the coming quarters.
Purchase price is approximately $350 million in cash; net of the present value of expected tax benefits of approximately $30 million, the net transaction value is approximately $320 million.
The transaction represents approximately 13.5x Basler's forecasted full-year 2025 adjusted EBITDA; Basler is expected to generate 2025 revenue of $125 million.
Littelfuse expects the acquisition to be accretive to adjusted diluted EPS in 2026 and expects closing by the end of the fourth quarter of 2025.
Basler, based in Highland, Illinois, has about 700 employees and will be reported in Littelfuse's Industrial Segment.
BXP reported third-quarter 2025 results showing a net loss attributable to BXP of $121.7 million, or $0.77 per diluted share, compared with net income of $89.0 million, or $0.56 per share, in the prior quarter. Revenue rose slightly to $871.5 million and diluted FFO per share increased to $1.74 from $1.71, but the loss reflects a non-cash impairment charge of approximately $145.1 million tied to unconsolidated joint ventures and $68.9 million of impairment losses on pending dispositions.
Net loss attributable to BXP of $121.7 million, or $0.77 per diluted share, for the quarter ended September 30, 2025, versus net income of $89.0 million, or $0.56 per share, for the quarter ended June 30, 2025
Total revenue of $871.5 million, up from $868.5 million in the prior quarter; diluted FFO per share of $1.74, up from $1.71
Non-cash impairment charge of approximately $145.1 million in loss from unconsolidated joint ventures, plus $68.9 million of impairment losses related to pending dispositions
Full-year 2025 guidance projects diluted EPS of $0.99 to $1.02 and diluted FFO per share of $6.89 to $6.92; quarterly dividend was $0.70 per share versus $0.98 in the prior quarter
American Assets Trust reported third-quarter 2025 results showing lower year-over-year profit and FFO, with total revenue of $109.6 million versus $122.8 million a year earlier. The company raised its 2025 FFO per diluted share guidance to $1.93 to $2.01, a $0.02 increase at the midpoint, which may matter to shareholders because it signals management's updated outlook despite weaker quarterly results.
Q3 2025 net income attributable to stockholders was $4.5 million, or $0.07 per diluted share, versus $16.7 million, or $0.28, in Q3 2024.
Q3 2025 FFO was $0.49 per diluted share versus $0.71 a year earlier; excluding lease termination fees and litigation income, it was $0.48 versus $0.56.
2025 FFO per diluted share guidance rose to $1.93 to $2.01 (midpoint $1.97) from $1.89 to $2.01.
The board declared a $0.340 per share dividend for Q4 2025, payable December 18, 2025 to holders of record as of December 4, 2025.
Everest Group agreed on October 26, 2025 to sell renewal rights for certain commercial property and casualty insurance lines to American International Group (AIG). The U.S. and rest-of-world portion has an aggregate purchase price of $252 million and closed October 26, 2025, while the European Union portion is priced at $49 million and still requires European Commission antitrust approval. The company says the deals sharpen its focus on reinsurance and its Global Wholesale and Specialty Insurance business, and that they will release significant capital over time.
ROW agreement: $252 million purchase price, with the transaction closing on October 26, 2025.
EU agreement: $49 million purchase price, pending European Commission antitrust approval and other customary closing conditions.
Purchase price is adjusted to 15% of actual 2025 premiums written; if renewed premiums fall below 80% of 2025 premiums, Everest may reimburse up to $70 million.
Jason Keen was appointed CEO of Global Wholesale and Specialty Insurance; AIG pays $10 million per month for nine months for transition services.
Sensata reported third-quarter 2025 revenue of $932.0 million, down 5.2% from a year earlier, and a loss of $1.12 per share including $259 million in charges tied to lower expected demand for electrification products. Adjusted EPS was $0.89, flat year over year, and fourth-quarter adjusted EPS guidance of $0.83 to $0.87 sits below the third-quarter level. The company also began tender offers for up to $350 million of senior notes and named Nicolas Bardot executive vice president and chief operations officer effective November 1, 2025.
Q3 revenue was $932.0 million, down $50.9 million or 5.2%; organic revenue rose 3.1%.
Q3 charges of about $259 million included a $225.7 million non-cash goodwill impairment tied to the Dynapower business.
Q3 adjusted EPS was $0.89, consistent with $0.89 a year earlier; GAAP loss per share was $1.12.
Q4 2025 guidance calls for revenue of $890 to $920 million and adjusted EPS of $0.83 to $0.87.
Zurn Elkay reported third-quarter 2025 net sales of $455 million, up 11% from $410 million a year earlier, and GAAP diluted EPS from continuing operations of $0.35 versus $0.25. The company raised its full-year 2025 adjusted EBITDA outlook to $437 million to $440 million from $420 million to $430 million, and also raised its dividend 22% and its share repurchase authorization to $500 million, which points to higher earnings and more cash returned to shareholders.
Q3 net sales $455 million vs. $410 million a year earlier (+11%); adjusted EPS $0.43 vs. $0.34 (+26%)
Q3 adjusted EBITDA $122 million (26.8% of net sales) vs. $105 million (25.6%)
Full-year 2025 adjusted EBITDA outlook raised to $437 million to $440 million from $420 million to $430 million
Annual dividend increased 22% to $0.44 per share; share repurchase authorization increased to $500 million
BrightSpring Health Services reported third-quarter 2025 revenue of $3,334 million, up 28.2% from a year earlier, and Adjusted EBITDA of $160 million, up 37.2%. The company raised its full-year 2025 revenue guidance and reiterated its Adjusted EBITDA guidance, which matters to shareholders because the headline sales and profit measures both improved.
Q3 2025 revenue was $3,334 million, up 28.2% from $2,601 million; continuing-operations net income was $37.5 million versus a net loss of $25.7 million a year earlier.
Adjusted EBITDA was $160 million, up 37.2% from $117 million.
2025 revenue guidance was raised to $12,500 million to $12,800 million; Adjusted EBITDA guidance of $605 million to $615 million was reiterated.
The planned sale of the Community Living business to Sevita is expected to close in Q1 2026.
Edison International reported third-quarter 2025 net income of $832 million, or $2.16 per share, up from $516 million, or $1.33 per share, a year earlier. The company narrowed its 2025 core EPS guidance to $5.95-$6.20 from $5.94-$6.34, and the filing says the Eaton Fire has been confirmed as a covered wildfire for accessing the Wildfire Fund.
Q3 2025 core earnings were $901 million, or $2.34 per share, versus $582 million, or $1.51 per share, in Q3 2024, driven mainly by higher SCE revenue from the 2025 GRC final decision.
2025 core EPS guidance narrowed to $5.95-$6.20, from $5.94-$6.34 as of July 31, 2025.
Wildfire Fund administrator confirmed the Eaton Fire as a covered wildfire for purposes of accessing the fund.
During Q3, SCE settled with one insurance claimant at 52 cents for each dollar paid to its policyholders; the company says this single data point is not enough to estimate total Eaton Fire losses.
Mondelēz International reported third-quarter 2025 net revenues of $9.7 billion, up 5.9%, but diluted EPS fell 9.5% to $0.57 and operating income fell 35.5% to $744 million. The company said cocoa cost inflation was at its peak in the third quarter and now expects 2025 Adjusted EPS to decline approximately 15% on a constant currency basis, with Organic Net Revenue growth of 4% or more.
Q3 net revenues $9.7 billion, up 5.9%; Organic Net Revenue up 3.4%, with volume/mix down 4.6 points
Q3 diluted EPS $0.57 versus $0.63 a year earlier; Adjusted EPS $0.73, down 24.2% on a constant currency basis
Updated 2025 outlook: Organic Net Revenue growth of 4%+ and Adjusted EPS down approximately 15% in constant currency; Free Cash Flow of $3+ billion still expected
Nine-month capital return to shareholders was $3.7 billion
W. P. Carey reported third-quarter 2025 revenues of $431.3 million, up 8.5% from a year earlier, and net income attributable to the company of $141.0 million, up 26.2%. The company raised and narrowed its full-year 2025 AFFO guidance to $4.93 to $4.99 per diluted share, citing higher expected investment volume, which matters to shareholders because AFFO is the company's main per-share earnings measure.
Q3 2025 revenues of $431.3 million, up 8.5% from $397.4 million in Q3 2024
Diluted EPS of $0.64 versus $0.51; AFFO of $1.25 per diluted share versus $1.18
2025 AFFO guidance raised and narrowed to $4.93 to $4.99 per diluted share, based on investment volume of $1.8 billion to $2.1 billion
Quarterly cash dividend of $0.910 per share, a 4.0% increase over the 2024 third quarter
EXL reported third-quarter 2025 results, with revenue up 12.2% year over year to $529.6 million and GAAP diluted EPS up 10.7% to $0.36. The company raised its full-year 2025 guidance for both revenue and adjusted diluted EPS, which points to stronger expected growth for shareholders, though operating income margin slipped to 14.4% from 14.7% a year earlier.
Q3 revenue of $529.6 million, up from $472.1 million in Q3 2024 (12.2% reported growth)
GAAP diluted EPS of $0.36 vs. $0.33 a year earlier; adjusted diluted EPS of $0.48 vs. $0.44
2025 revenue guidance raised to $2.07 billion to $2.08 billion; adjusted diluted EPS guidance raised to $1.88 to $1.92
Operating income margin of 14.4%, down from 14.7% in Q3 2024; conference call set for October 29, 2025 at 10:00 A.M. ET
InvenTrust reported third-quarter 2025 net income of $6.0 million, or $0.08 per diluted share, compared with a net loss of $0.5 million a year earlier, and total income rose to $74.5 million from $68.5 million. The company also updated 2025 guidance: net income per diluted share is now expected at $1.40 to $1.44, down from $1.43 to $1.49, while the Core FFO and same property NOI growth ranges moved higher, so shareholders see stronger operating measures alongside a lower earnings forecast.
Q3 2025 net income was $6.0 million, or $0.08 per diluted share, versus a net loss of $0.5 million, or $0.01 per share, in Q3 2024
Core FFO was $0.47 per diluted share versus $0.44 a year earlier; Nareit FFO was $0.49 versus $0.45
2025 net income per diluted share guidance is $1.40 to $1.44, down from $1.43 to $1.49; Core FFO guidance is $1.80 to $1.83, up from $1.79 to $1.83
Leased occupancy was 97.2% as of September 30, 2025; Net Debt-to-Adjusted EBITDA was 4.0x
Flowserve reported third-quarter 2025 sales of $1.17 billion, up 3.6% from a year earlier, and adjusted EPS of $0.90 versus $0.62. Reported diluted EPS was $1.67 versus $0.44, including a $266 million merger termination payment from the terminated Chart Industries merger. The company raised its 2025 adjusted EPS guidance to $3.40-$3.50 from $3.25-$3.40 and agreed to divest its legacy asbestos liabilities to Ajax HoldCo LLC, with closing expected in the fourth quarter of 2025.
Q3 sales were $1,174.4 million, up 3.6% year over year, and Q3 bookings were $1.2 billion.
Reported diluted EPS was $1.67 versus $0.44, including a $266 million Chart Industries merger termination payment.
Adjusted EPS was $0.90 versus $0.62; 2025 adjusted EPS guidance was raised to $3.40-$3.50 from $3.25-$3.40.
Asbestos liabilities divestiture to Ajax HoldCo LLC is expected to close in Q4 2025, with Parent contributing $199 million of about $219 million in cash.
CoStar Group reported third-quarter 2025 revenue of $834 million, up 20% from a year earlier, and raised its full-year 2025 adjusted EBITDA guidance to $415 million to $425 million. The company posted a GAAP net loss of $31 million, or $0.07 per diluted share, compared with net income of $53 million in the prior-year quarter, although non-GAAP net income rose 10% to $97 million.
Q3 2025 revenue was $834 million, up 20% from $693 million a year earlier
GAAP net loss was $31 million, or $0.07 per diluted share, versus net income of $53 million in Q3 2024
Adjusted EBITDA was $115 million in Q3, up 51% year over year
Full-year 2025 adjusted EBITDA guidance raised to $415 million to $425 million, a $40 million increase at the midpoint
Expand Energy reported third quarter 2025 results on October 28, 2025, with net income of $547 million, or $2.28 per diluted share, compared with a net loss of $114 million, or $0.85 per share, in the same quarter of 2024. The company also lowered the midpoint of its full-year 2025 capital expenditure guidance by $75 million to $2.85 billion and raised its production midpoint to 7.15 Bcfe/d, and plans to allocate $500 million to net debt paydown in the second half of 2025.
Q3 2025 net income of $547 million, or $2.28 per diluted share, vs. a net loss of $114 million, or $0.85 per share, in Q3 2024
Total revenues and other of $2,966 million vs. $648 million a year earlier; adjusted diluted EPS of $0.97 vs. $0.16
Full-year 2025 capital expenditure guidance midpoint cut by $75 million to $2.85 billion; production guidance midpoint raised by 50 MMcfe/d to 7.15 Bcfe/d
Quarterly base dividend of $0.575 per share payable December 4, 2025, to holders of record on November 13, 2025
Red Rock Resorts reported third-quarter 2025 results on October 28, 2025, with net revenues of $475.6 million, up 1.6%, and net income of $76.9 million, up 38.8% from a year earlier. The board also added $300 million to its share repurchase program, extended the program to December 31, 2027, and declared a $0.26 fourth-quarter dividend per Class A share.
Net revenues were $475.6 million, up 1.6% or $7.6 million from $468.0 million; adjusted EBITDA was $190.9 million, up 4.5%
Net income was $76.9 million, up 38.8% or $21.5 million from $55.4 million
Board authorized an additional $300 million under the $600 million repurchase program; about $573 million remains as of October 28, 2025
Fourth-quarter dividend of $0.26 per Class A share, payable December 31, 2025 to holders of record on December 15, 2025
Applied Industrial Technologies reported fiscal 2026 first quarter net sales of $1.2 billion, up 9.2% from a year earlier, and net income of $100.8 million, or $2.63 per diluted share, up 11.4%. The company raised its fiscal 2026 EPS guidance to $10.10 to $10.85 from $10.00 to $10.75, while reiterating its sales and EBITDA margin guidance.
Net sales of $1.2 billion rose 9.2%; organic sales rose 3.0%, and acquisitions contributed 6.3%.
Net income was $100.8 million, or $2.63 per diluted share, up 11.4% year over year; EBITDA was $146.3 million.
Fiscal 2026 EPS guidance raised to $10.10 to $10.85 from $10.00 to $10.75; sales guidance of up 4% to 7% and EBITDA margin guidance of 12.2% to 12.5% were maintained.
Quarterly cash dividend of $0.46 per share, payable November 28, 2025, to holders of record on November 14, 2025.
Albany International said it is exploring strategic alternatives for its structures assembly business, including a possible sale of all or part of the Salt Lake City facility. It also expects to record an approximately $147 million loss reserve adjustment in the third quarter of 2025, tied mainly to the CH-53K fixed-price contract, and said that without contract changes there is no path to profitability on the program as originally bid. The charge and the possible exit weigh on shareholders, while the company is in talks with its customer about contract modifications.
Approximately $147 million loss reserve adjustment expected in the third quarter of 2025, related to the CH-53K contract
Structures assembly is the only such program in the AEC segment; the site generated approximately $130 million of revenue, after EAC charges, for the twelve months ended September 30, 2025
Company is in ongoing discussions with its customer about potential contract modifications to offset cost increases
Third-quarter 2025 results are scheduled for release after market close on November 5, 2025, with a conference call and webcast on November 6, 2025
Hubbell reported third-quarter 2025 diluted EPS of $4.77, up from $4.18 a year earlier, and adjusted diluted EPS of $5.17, up from $4.61. Net sales rose 4% to $1,502.4 million. The company raised its full-year 2025 diluted EPS outlook to $16.55-$16.75 and its adjusted diluted EPS outlook to $18.10-$18.30, which shareholders would see as a higher earnings expectation for the year.
Q3 diluted EPS $4.77 vs. $4.18 in Q3 2024; adjusted diluted EPS $5.17 vs. $4.61
Q3 net sales $1,502.4 million, up 4% (organic up 3%); Grid Automation sales fell about 18%
2025 adjusted diluted EPS outlook raised to $18.10-$18.30; diluted EPS outlook $16.55-$16.75
Universal Health Services reported third-quarter 2025 net revenues up 13.4% to $4.495 billion and diluted EPS of $5.86, versus $3.80 a year earlier, and raised its full-year 2025 forecast for net revenues, Adjusted EBITDA net of NCI and Adjusted EPS-diluted. The board also added $1.5 billion to the stock repurchase authorization, bringing the available total to $1.759 billion, which matters to shareholders because it raises both the earnings outlook and the capacity for share buybacks.
Q3 2025 net income attributable to UHS was $373.0 million, or $5.86 per diluted share, versus $258.7 million, or $3.80, in Q3 2024
Q3 results included $90 million of pre-tax Medicaid reimbursements for Washington, D.C. and a $35 million pre-tax charge for professional and general liability reserves
2025 Adjusted EPS-diluted forecast raised to $21.50-$22.10 from $20.00-$21.00; net revenues forecast raised to $17.306-$17.445 billion
Board authorized a $1.5 billion increase to the stock repurchase program on October 27, 2025; 1.315 million shares repurchased in Q3 2025 for about $234.3 million
ATI reported third quarter 2025 sales of $1.13 billion, up 7% year over year, and GAAP diluted earnings per share of $0.78, up from $0.57. The company raised its full-year 2025 adjusted EPS and adjusted EBITDA ranges and repurchased $150 million of its stock during the quarter, which bears on shareholder returns and the outlook for per-share earnings.
Q3 2025 sales of $1.13 billion, up 7% year over year; net income attributable to ATI of $110 million, up 33%
Full-year 2025 adjusted EPS guidance raised to $3.15 to $3.21 from $2.90 to $3.07
Full-year 2025 adjusted EBITDA guidance raised to $848 million to $858 million from $810 million to $840 million
Repurchased $150 million of common stock in Q3 2025; $120 million of authorization remained at quarter end
Repligen reported third-quarter 2025 revenue of $189 million, up 22% from $155 million a year earlier, and GAAP net income of $15 million versus a $1 million loss in the prior-year quarter. The company raised its full-year 2025 revenue guidance to $729 million to $737 million, and GAAP diluted EPS guidance is $0.82 to $0.85.
Q3 2025 revenue was $189 million, up 22% as reported and 18% organic, with no COVID-related revenue in either period.
GAAP diluted EPS was $0.26 versus a loss of $0.01 a year earlier; adjusted diluted EPS was $0.46 versus $0.43.
Full-year 2025 revenue guidance was increased to $729 million to $737 million, with GAAP diluted EPS guidance of $0.82 to $0.85.
Cash and cash equivalents were $749 million at September 30, 2025, compared with $757 million at December 31, 2024.
Qorvo signed a merger agreement on October 27, 2025, with Skyworks Solutions under which Qorvo becomes a wholly owned subsidiary of Skyworks. Each Qorvo share would convert into 0.960 Skyworks shares plus $32.50 in cash, and Qorvo shares would be delisted from Nasdaq at closing. The deal requires Qorvo and Skyworks shareholder approval and regulatory clearances, with closing expected in early calendar 2027.
Each Qorvo share converts into 0.960 Skyworks shares plus $32.50 in cash
Qorvo shareholders would own about 37% of the combined company; Skyworks shareholders about 63%
Phil Brace to be chief executive of the combined company; Robert Bruggeworth to be one of three Qorvo-designated directors on an 11-member board
Closing expected early calendar 2027; either party may terminate if the Mergers are not completed by April 27, 2027, subject to extensions
Skyworks reported preliminary fourth-quarter and fiscal 2025 results and announced a definitive agreement to combine with Qorvo in a cash-and-stock transaction. The company also declared a quarterly dividend of $0.71 per share. The Qorvo deal is expected to close in early calendar 2027, subject to regulatory approvals and shareholder approvals, and the preliminary results may change after the year-end audit.
Preliminary fourth-quarter revenue was $1.10 billion, with GAAP diluted EPS of $1.07 versus $0.37 a year earlier and non-GAAP diluted EPS of $1.76 versus $1.55.
Preliminary fiscal 2025 revenue was $4.09 billion, with GAAP diluted EPS of $3.20 versus $3.69 and non-GAAP diluted EPS of $5.93 versus $6.27 in fiscal 2024.
The Qorvo combination is expected to close in early calendar 2027, subject to regulatory and shareholder approvals.
The $0.71 per share dividend is payable December 9, 2025, to holders of record on November 18, 2025.
Alkermes reported third-quarter 2025 total revenues of $394.2 million, up from $378.1 million a year earlier, while GAAP net income fell to $82.8 million, or $0.49 per diluted share, from $92.4 million, or $0.55 per diluted share, in the prior-year quarter. The company raised its 2025 expectations, including total revenues of $1,430 million to $1,490 million and GAAP net income of $230 million to $250 million, and the filing notes the proposed acquisition of Avadel Pharmaceuticals announced the prior week.
Q3 2025 total revenues were $394.2 million vs. $378.1 million in Q3 2024; LYBALVI revenues were $98.2 million, up 32%.
GAAP net income was $82.8 million ($0.49 diluted EPS) vs. $92.4 million ($0.55 diluted EPS) in Q3 2024.
2025 total revenue guidance raised to $1,430 million to $1,490 million from $1,340 million to $1,430 million; GAAP net income guidance raised to $230 million to $250 million from $175 million to $205 million.
Cash, cash equivalents and total investments were $1.14 billion at Sept. 30, 2025, vs. $1.05 billion at June 30, 2025.
American Tower reported third-quarter 2025 results, with total revenue up 7.7% to $2,717 million and net income attributable to common stockholders up 207.7% to $853 million, or $1.82 per diluted share. The company raised the midpoint of its full-year 2025 AFFO per share outlook by $0.10 to a range of $10.60 to $10.72, citing mainly estimated positive foreign currency effects, and declared a quarterly distribution of $1.70 per share.
Total revenue rose 7.7% to $2,717 million; total property revenue rose 5.9% to $2,616 million.
Net income attributable to common stockholders was $853 million, up 207.7%, mainly due to foreign currency losses in the prior-year period.
Full-year 2025 AFFO attributable to common stockholders per share midpoint raised by $0.10 to a range of $10.60 to $10.72.
Skyworks Solutions agreed to merge with Qorvo in a cash-and-stock transaction that the companies say values the combined enterprise at about $22 billion. Qorvo shareholders would receive $32.50 in cash and 0.960 of a Skyworks share per Qorvo share, and Skyworks holders would own about 63% of the combined company, which is expected to close in early calendar 2027 subject to shareholder and regulatory approvals.
Qorvo holders receive $32.50 in cash plus 0.960 Skyworks common shares per Qorvo share; Skyworks shareholders would own about 63% of the combined company
Goldman Sachs Bank USA committed up to $3,050,000,000 in senior unsecured bridge term loans; receipt of financing is not a closing condition
Companies expect $500 million or more of annual cost synergies within 24-36 months after closing; the deal is expected to close early in calendar 2027
Phil Brace will be chief executive officer of the combined company; Robert Bruggeworth will be a Qorvo designee on the board
Incyte reported third-quarter 2025 total revenues of $1.37 billion, up 20% from a year earlier, and GAAP net income of $424.2 million, or $2.11 per diluted share, compared with $106.5 million, or $0.54 per diluted share, in the prior-year quarter. The company raised its full-year 2025 net product revenue guidance to $4.23-$4.32 billion, while reiterating its guidance for cost of product revenues, R&D and SG&A expenses.
Total revenues were $1.37 billion, up 20%; total net product revenues were $1.15 billion, up 19%.
GAAP diluted EPS was $2.11 versus $0.54 a year earlier; GAAP net income was $424.2 million versus $106.5 million.
Jakafi net product revenue rose 7% to $791 million; Opzelura rose 35% to $188 million.
Full-year 2025 net product revenue guidance was raised to $4.23-$4.32 billion, from the prior range that the filing lists for Jakafi and other oncology products.
Xylem reported third-quarter 2025 revenue of $2.3 billion, up 8% on a reported basis and 7% organically, and reported diluted EPS of $0.93, up 4%. Adjusted EPS rose 23% to $1.37, and the company raised its full-year 2025 revenue and adjusted EPS guidance, which matters to shareholders because it reflects higher expected earnings for the year.
Q3 2025 revenue was $2.3 billion, up 8% reported and 7% organic; net income attributable to Xylem was $227 million
Q3 2025 EPS was $0.93 reported, up 4%, and $1.37 adjusted, up 23% from $1.11
Full-year 2025 revenue guidance is about $9.0 billion, up 5% to 6% reported versus 4% to 5% previously
Full-year 2025 adjusted EPS guidance is $5.03 to $5.08, up from the previous $4.70 to $4.85
Qorvo released preliminary results for its fiscal 2026 second quarter ended September 27, 2025, with revenue of $1,058.5 million, non-GAAP diluted EPS of $2.22 and non-GAAP gross margin of 49.7%, all above the midpoints of its prior guidance. The same day, Qorvo said it signed a definitive agreement to combine with Skyworks Solutions in a cash-and-stock deal that values the combined enterprise at approximately $22 billion, which would materially change the company's future for shareholders. The quarterly results are preliminary, unaudited and subject to change, and final results are due November 3, 2025.
Preliminary revenue of $1,058.5 million, versus prior guidance of $1,025 million plus or minus $50 million.
Non-GAAP diluted EPS of $2.22 versus prior guidance of $2.00 plus or minus 25 cents; non-GAAP gross margin of 49.7% versus guidance of 48% to 50%.
GAAP diluted EPS of $1.28, GAAP gross margin of 47.0% and GAAP net income of $119.6 million.
Definitive agreement with Skyworks Solutions in a cash-and-stock transaction; combined enterprise value of approximately $22 billion as of the October 27, 2025 market close.
PayPal reported third-quarter 2025 net revenues of $8.4 billion, up 7% year over year, and GAAP diluted EPS of $1.30, up 32%. The company raised its full-year 2025 non-GAAP EPS guidance to $5.35-$5.39 and announced its first quarterly cash dividend of $0.14 per share, payable December 10, 2025, to holders of record on November 19, 2025.
Q3 2025 net revenues rose 7% to $8.4 billion; non-GAAP EPS rose 12% to $1.34.
Full-year 2025 non-GAAP EPS guidance raised to $5.35-$5.39; GAAP EPS guidance set at $5.11-$5.15.
Quarterly dividend of $0.14 per share, payable December 10, 2025, to holders of record on November 19, 2025.
Q3 share repurchases totaled $1.5 billion, about 21 million shares.
A. O. Smith reported third-quarter 2025 net sales of $942.5 million, up 4%, and diluted EPS of $0.94, up 15% from $0.82 a year earlier. The company lowered its full-year 2025 sales outlook to flat to up 1% and narrowed its diluted EPS range to $3.70 to $3.85, with management citing China headwinds and weaker new home construction in North America, which matters to shareholders because the outlook is weaker even as recent results grew.
Q3 2025 net sales of $942.5 million, up 4%; net earnings of $132.0 million, up 10%; diluted EPS of $0.94, up 15%
Full-year 2025 consolidated sales now projected flat to up 1% versus 2024 actual of $3,818 million
Diluted EPS outlook narrowed to $3.70 to $3.85, with the midpoint lowered according to the CEO; 2024 diluted EPS was $3.63
China sales fell 12% in local currency in the quarter; board approved a 6% dividend increase on October 13, 2025
Carrier reported third-quarter 2025 net sales of $5.6 billion, down 7% from a year earlier, and GAAP operating profit of $539 million, down 29%. The company cut its full-year 2025 guidance, with adjusted EPS now about $2.65 versus the prior $3.00 to $3.10, and its board approved a $5 billion increase to the share repurchase authorization, bringing the amount available to about $5.8 billion.
Q3 net sales $5.6 billion, down 7%; organic sales down 4%
Diluted GAAP EPS from continuing operations $0.47 vs. $0.62 a year earlier; adjusted EPS $0.67 vs. $0.77
Full-year 2025 guidance: sales about $22 billion (prior about $23 billion); adjusted EPS about $2.65 (prior $3.00 to $3.10)
Board approved $5 billion buyback increase, effective October 28, 2025; authorization has no time limit
Labcorp reported third-quarter 2025 revenue of $3.56 billion, up from $3.28 billion, and diluted EPS of $3.12, up from $2.00. It raised its full-year adjusted EPS guidance midpoint by $0.05 and its free cash flow guidance midpoint by $25 million, but lowered its revenue growth guidance midpoint by 40 basis points, citing currency and acquisition timing.
Q3 revenue was $3.56 billion versus $3.28 billion a year earlier; adjusted EPS was $4.18 versus $3.50.
Full-year adjusted EPS guidance is now $16.15 to $16.50, with the midpoint raised by $0.05.
Full-year revenue growth guidance is 7.4% to 8.0%, with the midpoint lowered 40 basis points due to currency and acquisition timing.
Free cash flow guidance is $1.17 billion to $1.29 billion, with the midpoint raised by $25 million.
Tenet Healthcare reported third quarter 2025 revenue of $5.289 billion, up 3.2% from a year earlier, and adjusted diluted EPS of $3.70, up 26.3%. GAAP net income available to common shareholders fell to $342 million from $472 million, mainly because the prior-year quarter included a $348 million pre-tax gain on the Brookwood Baptist Health sale. The company raised its full-year 2025 Adjusted EBITDA outlook to $4.47 billion to $4.57 billion, a $50 million increase at the midpoint.
Q3 2025 net operating revenues were $5.289 billion, up from $5.126 billion; Adjusted EBITDA rose 12.4% to $1.099 billion
Q3 2025 diluted EPS was $3.86 versus $4.89 a year earlier; adjusted diluted EPS was $3.70 versus $2.93
FY 2025 Adjusted EBITDA outlook is $4.47 billion to $4.57 billion, a $50 million increase at the midpoint
Nine-month free cash flow was $2.163 billion; the company repurchased $93 million of stock in Q3 2025
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.